Zhen Mahoney, Ph.D., Emba Email & Phone Number

Santa Clara, Ca, Us

Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing innovative technology solutions to improve the quality of life. The DAKO brand at Agilent is a trusted name among pathologists and clinical laboratories around the world. Agilent/DAKO developed the first companion diagnostic (CDx) test, HercepTest, over 20 years ago and ushered in the era of precision medicine. Over the years, eight additional CDx tests from Agilent/DAKO have been approved by the US FDA, including the PD-L1 IHC 22C3 pharmDx for Keytruda (Pembrolizumab) and PD-L1 IHC 28-8 pharmDx for Opdivo (nivolumab). Currently, 89 countries have access to an Agilent PD-L1 diagnostic kit and over 1 million patients have been tested with Agilent's PD-L1 diagnostic kits.Agilent completed the acquisition of Resolution Bioscience in April 2021, a leader in next-generation sequencing (NGS)-based precision oncology solutions. Resolution Bioscience has submitted PMA application for the Resolution ctDx FIRST liquid biopsy assay in conjunction with Mirati Therapeutics for NSCLC. The Resolution HRD liquid biopsy assay has been granted Breakthrough Device Designation by the US FDA and is being developed as a CDx with a major pharma partner.Send your inquiry to CDxPartnerships@agilent.com if you are interested in learning more!

Leverkusen, North Rhine-Westphalia, De

A member of the Vitrakvi (Larotrectinib, TRK inhibitor) brand marketing team. Lead pathologist KOL mapping, congress, and speaker programs; develop promotional materials; support field sales force; manage team budget; execute innovative Dx partnership programs; collaborate with global marketing, medical affairs, market access, data insight, learning & development, patient advocacy, regulatory, legal, finance, compliance, agencies, and other cross-functional teams.

Austin, Texas, Us

In this role, I oversee business development, with accountability for team performance, department budget administration, and strategic planning.I have strengthened the company’s competitive distinction through market segmentation, positioning, messaging, conference presence, and external stakeholder interactions.My scope of accomplishments includes negotiating and closing the largest deal in the history of the company and setting precedent as the first Companion Diagnostics agreement for neurological diseases in the industry.I have been able to grow the Custom Diagnostic business by 15%, using a combination of business analytics and effective account management strategies.My achievements also encompass product development, where I have brought an idea through business case development and the creation of a proof of concept. I have directed market assessments of four product concepts.

South San Francisco, California, Us

As the Director of Applied Markets for APAC, I launched and led a new business unit dedicated to the APAC region, which ranked as the only territory with positive revenue growth in 2016, where I skyrocketed revenue in China by 97%.I also formed strategic partnerships in China that enabled the company to penetrate the Diagnostics market.As the Director of Sales for the South-Central US, I established a reputation for exceeding sales goals and building a pipeline of opportunities for equipment sales ranging from $500K to $1M per unit.My achievements included the leadership of the North America Sales Team to establish business with comprehensive cancer centers. I also negotiated the first content licensing agreement in the 18-year history of the company.

Waltham, Ma, Us

I was promoted multiple times within Thermo Fisher Scientific, transitioning from a Scientist role to sales and business development.As Senior Pharmaceutical Business Development Lead, I sold $2MM in subscriptions to the Oncomine cancer genomics database to the Top 20 pharmaceutical companies and captured a 50% gain in sales of a genetic analysis product to CROs.As Genetic Analysis System Sales Representative / Ion Torrent Delta Force, I secured a 30% growth in territory sales in 2010 and a 60% growth in 2011 and achieved 220% of instrument sales goal in 2012. I was selected for the Ion Torrent Delta Force, leading NGS instrument sales within the district.I started with the company as a Field Application Scientist, where I oversaw a 30-person team in the production of the Fragment Analysis Application User Guide (300+ pages).

Ph.D., Advanced Genetics And Genomics

Master Of Business Administration - Mba

Bachelor Of Science - Bs, Biochemistry & Molecular Biology